WilmerHale are most popular:
- within Employment and HR topic(s)
In 2023, pharmaceutical patent owners filed nearly 250 infringement complaints against generic drug manufacturers. More than 90% of those cases were filed in the Districts of Delaware or New Jersey.
Click here to continue reading . . .
Originally published Law360 on 1 December, 2023
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
[View Source]
